Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylation

MLA

Jesus Paez-Mayorga, et al. “Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylation.” Frontiers in Cardiovascular Medicine, vol. 5, May 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a7317a203968e1966635cde1d030bd03&authtype=sso&custid=ns315887.

APA

Jesus Paez-Mayorga, Andrew L. Chen, Sivareddy Kotla, Yunting Tao, Rei J. Abe, Emma D. He, Brian P. Danysh, Marie-Claude C. Hofmann, & Nhat-Tu Le. (2018). Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylation. Frontiers in Cardiovascular Medicine, 5.

Chicago

Jesus Paez-Mayorga, Andrew L. Chen, Sivareddy Kotla, Yunting Tao, Rei J. Abe, Emma D. He, Brian P. Danysh, Marie-Claude C. Hofmann, and Nhat-Tu Le. 2018. “Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylation.” Frontiers in Cardiovascular Medicine 5 (May). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a7317a203968e1966635cde1d030bd03&authtype=sso&custid=ns315887.